JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Scope & Guideline

Transforming cardiovascular therapies for better patient outcomes.

Introduction

Welcome to your portal for understanding JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1074-2484
PublisherSAGE PUBLICATIONS INC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationJ CARDIOVASC PHARM T / J. Cardiovasc. Pharmacol. Ther.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2455 TELLER RD, THOUSAND OAKS, CA 91320

Aims and Scopes

The Journal of Cardiovascular Pharmacology and Therapeutics aims to advance knowledge in the field of cardiovascular pharmacotherapy. It publishes research focusing on the development, efficacy, and safety of pharmacological treatments for cardiovascular conditions, as well as innovative therapeutic approaches and their clinical implications.
  1. Pharmacological Interventions for Cardiovascular Diseases:
    The journal emphasizes studies on various pharmacological agents used to treat cardiovascular diseases, including novel therapies and existing medications, assessing their safety and efficacy.
  2. Clinical Outcomes and Real-World Evidence:
    Research that evaluates the outcomes of cardiovascular treatments in clinical practice, including observational studies and real-world data analyses, is a core focus.
  3. Mechanistic Studies in Cardiovascular Pharmacology:
    Investigations into the underlying mechanisms of action of cardiovascular drugs, including molecular and cellular pathways, are regularly featured.
  4. Therapeutic Innovations and Trials:
    The journal places a strong emphasis on clinical trials and innovative therapeutic approaches, including combination therapies and new drug formulations.
  5. Impact of Comorbidities on Cardiovascular Treatment:
    Research examining how comorbid conditions (e.g., diabetes, chronic kidney disease) affect cardiovascular treatment outcomes is a prominent theme.
The Journal of Cardiovascular Pharmacology and Therapeutics has increasingly embraced new and emerging themes in cardiovascular research. Recent publications indicate a shift towards exploring innovative therapies and addressing contemporary challenges in cardiovascular care.
  1. SGLT2 Inhibitors and Heart Failure:
    There is a growing focus on the role of SGLT2 inhibitors in treating heart failure, especially in patients with diabetes, highlighting their multifaceted benefits.
  2. Personalized Medicine and Genotyping:
    Emerging studies emphasize the importance of personalized medicine approaches, including genotyping for anticoagulant therapy, reflecting a trend towards individualized treatment strategies.
  3. Impact of Lifestyle Factors on Cardiovascular Health:
    Research exploring the effects of lifestyle factors—such as diet, physical activity, and smoking—on cardiovascular health and treatment outcomes is gaining traction.
  4. Cardiovascular Effects of Novel Therapies:
    An increased interest in the cardiovascular implications of non-cardiovascular drugs and therapies, including those used in cancer treatment, is evident in recent publications.
  5. Integrative Approaches to Cardiovascular Care:
    There is a notable trend towards integrative strategies combining pharmacological and non-pharmacological interventions, emphasizing holistic patient management.

Declining or Waning

While the journal has consistently focused on cardiovascular pharmacotherapy, certain themes have seen a decline in publication frequency or relevance. These waning scopes may reflect shifting research priorities or advancements in treatment paradigms.
  1. Traditional Antihypertensive Agents:
    Research focusing solely on traditional antihypertensive medications has decreased, as newer agents and combination therapies are gaining prominence.
  2. Static Observational Studies:
    The prevalence of static observational studies without innovative designs or significant clinical implications appears to be declining, as the journal increasingly favors studies with robust methodologies and real-world applications.
  3. Basic Science without Clinical Relevance:
    Papers focusing solely on basic science aspects of cardiovascular pharmacology, lacking direct clinical relevance or application, have been published less frequently.

Similar Journals

PROGRESS IN CARDIOVASCULAR DISEASES

Transforming Knowledge into Clinical Practice
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0033-0620Frequency: 6 issues/year

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

Archives of Cardiovascular Diseases

Transforming the future of cardiology with innovative insights.
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1875-2136Frequency: 12 issues/year

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

CIRCULATION

Leading the Charge in Heart Health Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

CARDIOVASCULAR DRUGS AND THERAPY

Elevating standards in cardiovascular drug therapy.
Publisher: SPRINGERISSN: 0920-3206Frequency: 6 issues/year

CARDIOVASCULAR DRUGS AND THERAPY, published by Springer, is a premier journal dedicated to the latest advances in cardiovascular pharmacology and therapeutics. With a significant impact factor and esteemed rankings in cardiology and pharmacology, this journal is positioned in the top quartile categories, reflecting its influence and contribution to the field. Since its inception in 1987, the journal has served an international audience, providing a platform for researchers and practitioners to publish high-quality original research, critical reviews, and innovative clinical studies that address pressing issues in cardiovascular health. The journal's rigorous peer-review process ensures the utmost scholarly merit, making it an essential resource for professionals aiming to stay at the forefront of cardiovascular drug research and therapy. While not an open-access publication, it is widely available through institutional subscriptions, enhancing its reach within the global community of cardiology researchers and practitioners. Located in the Netherlands, CARDIOVASCULAR DRUGS AND THERAPY continues to play a vital role in advancing our understanding of cardiovascular diseases and the pharmacological solutions available to combat them.

Anatolian Journal of Cardiology

Bridging Knowledge Gaps in Cardiology for a Healthier Tomorrow.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Nepalese Heart Journal

Elevating Cardiology Practices in Nepal and Beyond
Publisher: CARDIAC SOC NEPALISSN: 2091-2978Frequency: 1 issue/year

Nepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.

Heart Views

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1995-705XFrequency: 4 issues/year

Heart Views is a prestigious and influential journal dedicated to the field of cardiology and cardiovascular medicine, published by Wolters Kluwer Medknow Publications. With an Open Access model implemented since 2010, the journal ensures that its valuable research findings are accessible to a global audience, fostering knowledge dissemination and collaboration among researchers, professionals, and students alike. While the current impact factor is not specified, its commitment to quality and peer-reviewed content has established it as a significant resource within the cardiology community. The journal publishes a diverse array of articles, including original research, reviews, and clinical studies aimed at advancing the understanding and treatment of cardiovascular diseases. Heart Views serves as an essential platform for sharing innovative ideas and practices, thereby contributing to improved patient care and outcomes in the dynamic field of heart health.

American Journal of Preventive Cardiology

Pioneering Solutions for Cardiovascular Challenges.
Publisher: ELSEVIERISSN: 2666-6677Frequency: 4 issues/year

American Journal of Preventive Cardiology, published by ELSEVIER, is a premier Open Access journal that has been making significant strides in the field of cardiology since its inception in 2020. With an impressive impact factor and recognized as a Q1 journal in the Cardiology and Cardiovascular Medicine category as of 2023, it ranks 77th out of 387 in the Scopus database, placing it in the 80th percentile of its field. The journal aims to promote the latest research and practices in preventive cardiology, addressing the global burden of cardiovascular diseases through a combination of innovative findings and practical applications. With the advantage of Open Access, all published articles are readily available to researchers, professionals, and students worldwide, fostering a broad dissemination of knowledge and encouraging collaboration across disciplines. Based in Amsterdam, Netherlands, the journal is committed to advancing the science and prevention of heart disease, making it an essential resource for those dedicated to improving cardiovascular health.

American Journal of Cardiovascular Drugs

Pioneering Research in Cardiovascular Pharmacology
Publisher: ADIS INT LTDISSN: 1175-3277Frequency: 6 issues/year

American Journal of Cardiovascular Drugs, published by ADIS INT LTD, is a premier peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. With an ISSN of 1175-3277 and an E-ISSN of 1179-187X, this esteemed journal has established itself as a crucial platform for disseminating high-quality research since its inception in 2001. It holds a significant position in its domain, ranking in the second quartile (Q2) across several categories including Cardiology, Medicine (miscellaneous), and Pharmacology (medical) for the year 2023. With its Scopus ranks placing it in the 81st percentile for Cardiology and 77th percentile for Pharmacology, the journal is highly regarded among professionals, researchers, and students alike. While it is not an open-access journal, its comprehensive articles and systematic reviews provide an in-depth exploration of cardiovascular drug therapy, therapeutic advancements, and clinical practices, making it an invaluable resource for anyone invested in the future of cardiovascular health.

Expert Review of Clinical Pharmacology

Advancing clinical care through expert pharmacological insights.
Publisher: TAYLOR & FRANCIS LTDISSN: 1751-2433Frequency: 12 issues/year

Expert Review of Clinical Pharmacology, published by TAYLOR & FRANCIS LTD, is a leading peer-reviewed journal dedicated to the field of clinical pharmacology, with a strong focus on the development and application of pharmacological therapies in patient care. Boasting an impressive impact, the journal ranks in the first quartile across multiple categories including Medicine (miscellaneous), Pharmacology (medical), and Pharmacology, Toxicology and Pharmaceutics (miscellaneous), reflecting its influential position within the scientific community. With a Scopus ranking of #6 in General Pharmacology, Toxicology and Pharmaceutics, the journal also achieves a commendable 93rd percentile, further emphasizing its importance as a resource for researchers and clinicians alike. As it continues to publish innovative reviews and research articles from 2008 until 2024, the Expert Review of Clinical Pharmacology plays an essential role in advancing knowledge, improving clinical practice, and fostering collaboration among experts in pharmacology, thereby driving forward the field's evolution towards better patient outcomes.